Zimmer Biomet Holdings (NYSE: ZBH) reported Q3 EPS of $1.64, $0.08 better than the analyst estimate of $1.56. Revenue for the quarter came in at $1.76 billion versus the consensus estimate of $1.76 billion.

Zimmer Biomet Holdings sees FY2015 EPS of $6.83-$6.87, versus prior guidance of $6.65-$6.80 and the consensus of $6.73.

For earnings history and earnings-related data on Zimmer Biomet Holdings (ZBH) click here.